Mofebutazone sodium
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384628This classification denotes a nonsteroidal antiinflammatory drug C13H15N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 73X92I1U1W, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-phenyl-, sodium salt (1:1), but more generally known as mofebutazone sodium, which bears US NIH Compound Identifier 16639. European Medicines Agency schedules Mofebutazone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03313MIG. Most nations, for tariff and trade purposes, schedule mofebutazone sodium under HS 29331990 and SITC 51571. As of Q4 2014, MOFEBUTAZONE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CCCC[C-]1C(=O)[NH]N(C1=O)C2CCCCC2.[NA+].
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.